+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Iliac Stent Market Size, Share & Trends Analysis Report By Type (Self-expandable Stents, Balloon-expandable Stents), By Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Lesion), By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 130 Pages
  • February 2024
  • Region: Global
  • Grand View Research
  • ID: 5943884
Description Jump to:
The globall iliac stent market size is expected to reach USD 1.53 billion by 2030, projected to grow at a CAGR of 5.8% from 2024 to 2030. The market is expected to grow due to factors such as the increasing prevalence of peripheral artery diseases, growing advancements in medical technology, and expanding awareness about minimally invasive procedures as an effective treatment option for cardiovascular diseases.

The industry's growth is driven by new product development and aligned procedures with enhanced patency. For instance, self-expanding stents have demonstrated exceptional results in the treatment of external iliac artery. Furthermore, the growing prevalence of peripheral artery disease (PAD) is expected to propel iliac stents market growth. According to an article by the Institute for Health Metrics and Evaluation in October 2023, the global prevalence of PAD was pegged at 1.52% or nearly 113 million people. Additionally, NCBI's article in 2022 projected the annual incidence of PAD to be nearly 10 million.

An increase in strategic initiatives amongst the key players of iliac stents is anticipated to propel growth. For instance, in January 2024, Zylox-Tonbridge Medical Technology Co., Ltd. received marketing approval from the National Medical Products Administration (NMPA) for its peripheral venous stent system. Furthermore, in October 2023, Getinge AB announced the commercial availability of its product, iCast covered stent system to treat iliac arterial occlusive disease in the U.S.

Iliac Stents Market Report Highlights

  • The iliac stents marketin the healthcare industry was estimated at USD 1.03 Billion in 2023 and is expected to reach USD 1.53 Billion in 2030
  • The iliac stents marketis expected to grow at a compound annual growth rate of 5.8% from 2024 to 2030 to reach USD 1.53 Billion by 2030
  • In 2023, North America held the largest share in the iliac stents market, with a revenue share of 43.7%. The growing geriatric population in the U.S., which is susceptible to PAD is expected to increase the demand for stenting procedures, thereby significantly contributing to the market growth over the forecast period
  • By type, self-expandable stents segment accounted for the largest revenue share of 60.4% in 2023driven by favorable long-term clinical study results for these stents that are expected to instill confidence in healthcare providers
  • By artery lesions, the common iliac artery lesions segment accounted for the largest revenue share of 60.5% in 2023 driven by growing cases of patients suffering from high cholesterol and obesity are expected to boost the demand for iliac stents, as these conditions cause plaque buildup, which narrows or blocks artery lumen
  • By end use, hospital segment accounted for a dominant revenue share of 61.7% in 2023. Hospitals serve as referral centers where patients receive comprehensive care, including diagnostic imaging, medical management, and interventional procedures like iliac stent placement

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Artery lesions
1.2.3. End-use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for Primary Interviews in North America
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Parent market analysis (Model 2)
1.7.4. Approach 2: Parent market analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment outlook
2.2.1. Type outlook
2.2.2. Artery lesions outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Iliac Stents Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing prevalence of peripheral artery disease (PAD)
3.2.1.2. Technological advancements in iliac stents
3.2.1.3. Increasing number of product approvals in developed and developing countries
3.2.2. Market Restraint Analysis
3.2.2.1. Lack of reimbursement policies for venous stenting
3.2.2.2. Product recalls
3.3. Iliac Stents Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic Landscape
Chapter 4. Iliac Stents Market: Type Estimates & Trend Analysis
4.1. Iliac Stent Market: Type Dashboard
4.2. Iliac Stent Market: Type Movement Analysis
4.3. Iliac Stents Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Self-Expandable Stents
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Balloon-Expandable Stents
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Others
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Iliac Stents Market: Artery Lesions Estimates & Trend Analysis
5.1. Iliac Stent Market: Artery Lesions Dashboard
5.2. Iliac Stent Market: Artery Lesions Movement Analysis
5.3. Iliac Stents Market Size & Forecasts and Trend Analysis, by Artery Lesion, 2018 to 2030 (USD Million)
5.4. Common Iliac Artery Lesions
5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Severe Calcified Lesions
5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Complete Obstructive Lesions
5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Iliac Stents Market: End-Use Estimates & Trend Analysis
6.1. Iliac Stent Market: End-Use Dashboard
6.2. Iliac Stent Market: End-Use Movement Analysis
6.3. Iliac Stents Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals
6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Outpatient Facilities
6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Others
6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Iliac Stents Market: Regional Estimates & Trend Analysis by Country, Type, Artery Lesions, & End-use
7.1. Regional Dashboard
7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
7.3. North America
7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.3.2. U.S.
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.3.3. Canada
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework/ reimbursement structure
7.3.3.3. Competitive scenario
7.3.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.4. Europe
7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.4.2. UK
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. Germany
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.4.4. France
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.4.5. Italy
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.4.6. Spain
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.4.7. Norway
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.4.8. Sweden
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.4.9. Denmark
7.4.9.1. Key country dynamics
7.4.9.2. Regulatory framework/ reimbursement structure
7.4.9.3. Competitive scenario
7.4.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.5.2. Japan
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. China
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. India
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.5.5. Australia
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.5.6. South Korea
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.5.7. Thailand
7.5.7.1. Key country dynamics
7.5.7.2. Regulatory framework/ reimbursement structure
7.5.7.3. Competitive scenario
7.5.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Latin America
7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6.2. Brazil
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. Mexico
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.6.4. Argentina
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework/ reimbursement structure
7.6.4.3. Competitive scenario
7.6.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. South Africa Market Estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key Country Dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. BD
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Abbott
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Boston Scientific Corporation
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. W. L. Gore & Associates, Inc.
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Cook
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Medtronic
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Vascular
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Terumo Corporation
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Getinge AB
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Biotronik SE & Co KG
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 North America Iliac Stents market, by country, 2018 - 2030 (USD Million)
Table 3 North America Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 4 North America Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 5 North America Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
Table 6 U.S. Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 7 U.S. Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 8 U.S. Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
Table 9 Canada Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 10 Canada Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 11 Canada Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
Table 12 Europe Iliac Stents market, by country, 2018 - 2030 (USD Million)
Table 13 Europe Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 14 Europe Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 15 Europe Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
Table 16 Germany Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 17 Germany Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 18 Germany Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
Table 19 UK Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 20 UK Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 21 UK Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
Table 22 France Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 23 France Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 24 France Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
Table 25 Italy Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 26 Italy Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 27 Italy Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
Table 28 Spain Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 29 Spain Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 30 Spain Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
Table 31 Denmark Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 32 Denmark Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 33 Denmark Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
Table 34 Sweden Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 35 Sweden Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 36 Sweden Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
Table 37 Norway Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 38 Norway Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 39 Norway Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
Table 40 Asia Pacific Iliac Stents market, by country, 2018 - 2030 (USD Million)
Table 41 Asia Pacific Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 42 Asia Pacific Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 43 Asia Pacific Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
Table 44 China Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 45 China Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 46 China Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
Table 47 Japan Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 48 Japan Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 49 Japan Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
Table 50 India Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 51 India Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 52 India Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
Table 53 South Korea Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 54 South Korea Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 55 South Korea Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
Table 56 Australia Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 57 Australia Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 58 Australia Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
Table 59 Thailand Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 60 Thailand Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 61 Thailand Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
Table 62 Latin America Iliac Stents market, by country, 2018 - 2030 (USD Million)
Table 63 Latin America Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 64 Latin America Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 65 Latin America Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
Table 66 Brazil Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 67 Brazil Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 68 Brazil Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
Table 69 Mexico Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 70 Mexico Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 71 Mexico Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
Table 72 Argentina Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 73 Argentina Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 74 Argentina Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
Table 75 MEA Iliac Stents market, by country, 2018 - 2030 (USD Million)
Table 76 MEA Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 77 MEA Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 78 MEA Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
Table 79 South Africa Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 80 South Africa Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 81 South Africa Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
Table 85 UAE Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 86 UAE Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 87 UAE Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
Table 88 Kuwait Iliac Stents market, by type, 2018 - 2030 (USD Million)
Table 89 Kuwait Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
Table 90 Kuwait Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Iliac Stents Market Segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Type and artery lesions segment snapshot
Fig. 10 End-use segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Market dynamics
Fig. 13 Prevalence of PAD in 2022, by WHO regions
Fig. 14 Porter’s Five Forces analysis
Fig. 15 PESTLE analysis
Fig. 16 Iliac Stents market: Type outlook and key takeaways
Fig. 17 Iliac Stents market: Type movement analysis
Fig. 18 Self-expandable stents market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Balloon expandable stents market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Iliac Stents market: Artery Lesions outlook and key takeaways
Fig. 22 Iliac Stents market: Artery Lesions movement analysis
Fig. 23 Common Iliac Artery Lesions market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Severe Calcified Lesions market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Complete Obstructive Lesions market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Iliac Stents market: End-use outlook and key takeaways
Fig. 27 Iliac Stents market: End-use movement analysis
Fig. 28 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Outpatient Facilities market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Iliac Stents market revenue, by region, 2023 & 2030 (USD Million)
Fig. 32 Regional marketplace: Key takeaways (1/2)
Fig. 33 Regional marketplace: Key takeaways (2/2)
Fig. 34 North America Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Key country dynamics
Fig. 36 U.S. Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Key country dynamics
Fig. 38 Canada Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Europe Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Key country dynamics
Fig. 41 UK Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Key country dynamics
Fig. 43 Germany Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Key country dynamics
Fig. 45 France Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Key country dynamics
Fig. 47 Spain Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Key country dynamics
Fig. 49 Italy Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Key country dynamics
Fig. 51 Denmark Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Key country dynamics
Fig. 53 Sweden Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Key country dynamics
Fig. 55 Norway Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Rest of Europe Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Asia Pacific Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Key country dynamics
Fig. 59 Reimbursement scenario
Fig. 60 Japan Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Regulatory framework
Fig. 63 Reimbursement scenario
Fig. 64 China Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 Reimbursement scenario
Fig. 67 India Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 Australia Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 South Korea Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 Thailand Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 Malaysia Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 Vietnam Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 Philippines Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Rest of Asia Pacific Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Latin America Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Key country dynamics
Fig. 83 Brazil regulation details
Fig. 84 Reimbursement scenario
Fig. 85 Brazil Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Key country dynamics
Fig. 87 Argentina pharmaceuticals registration details
Fig. 88 Argentina Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Key country dynamics
Fig. 90 Regulatory framework
Fig. 91 Reimbursement scenario
Fig. 92 Mexico Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 Rest of Latin America Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 94 MEA Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 Key country dynamics
Fig. 96 South Africa Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 97 Key country dynamics
Fig. 98 Saudi Arabia Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 99 Key country dynamics
Fig. 100 UAE Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 101 Key country dynamics
Fig. 102 Kuwait Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 103 Key country dynamics
Fig. 104 Rest of MEA Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 105 Company market share analysis, 2023
Fig. 106 Strategic Framework

Companies Mentioned

  • BD
  • Abbott
  • Boston Scientific Corporation
  • W. L. Gore & Associates, Inc.
  • Cook
  • Medtronic
  • Vascular
  • Terumo Corporation
  • Getinge AB
  • Biotronik SE & Co KG

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages130
PublishedFebruary 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 1.03 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.53 Billion
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Iliac Stent Global Market Report 2024 - Product Image

Iliac Stent Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Iliac Stent Market Size, Share & Trends Analysis Report By Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Lesions, and Complete Obstructive Lesions), By End-use, By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Iliac Stent Market Size, Share & Trends Analysis Report By Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Lesions, and Complete Obstructive Lesions), By End-use, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • 226 Pages
  • Global
From
Asia Pacific Iliac Stent Market Size, Share & Trends Analysis Report By Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Lesions, and Complete Obstructive Lesions), By End-use, By Country and Growth Forecast, 2023 - 2030 - Product Image

Asia Pacific Iliac Stent Market Size, Share & Trends Analysis Report By Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Lesions, and Complete Obstructive Lesions), By End-use, By Country and Growth Forecast, 2023 - 2030

  • Report
  • 119 Pages
  • Asia Pacific
From
Arterial Stents - Global Strategic Business Report - Product Image

Arterial Stents - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Stents Market Size, Share & Trends Analysis Report by Product (Vascular, Non-vascular), Material (Metallic, Non-metallic), End-use (Hospitals, Ambulatory Care Centers, Specialty Clinics), Region, and Segment Forecasts, 2025-2030 - Product Image

Stents Market Size, Share & Trends Analysis Report by Product (Vascular, Non-vascular), Material (Metallic, Non-metallic), End-use (Hospitals, Ambulatory Care Centers, Specialty Clinics), Region, and Segment Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From

About the Iliac Stent Market

The Iliac Stent market is a subset of the larger Stent market, which is composed of medical devices used to treat narrowed or blocked arteries. Iliac Stents are specifically designed to treat blockages in the iliac arteries, which are the two large arteries that supply blood to the legs. These stents are typically made of metal mesh and are inserted into the artery to keep it open and allow for improved blood flow. Iliac Stents are used to treat a variety of conditions, including peripheral artery disease, aortoiliac occlusive disease, and chronic total occlusions. They are also used to treat aneurysms and other vascular diseases. The stents are typically inserted using a minimally invasive procedure, which reduces the risk of complications and recovery time. Some companies in the Iliac Stent market include Abbott, Boston Scientific, Medtronic, and Cook Medical. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.